Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 25, 2012

View Archived Issues

Promising nanoparticle-based dental treatment developed in Germany

Add-on apricoxib therapy may benefit subset of patients with pancreatic cancer

First HSP 90 inhibitor assessed in individuals with colorectal cancer

PI3K inhibitors active against gastrointestinal cancer cells

Ranbaxy Laboratories discloses novel 5-lipoxygenase inhibitors

Novel muscarinic acetylcholine M3 receptor antagonists presented

GlaxoSmithKline designs new bromodomain-containing protein inhibitors

Acura Pharmaceuticals provides Oxecta commercial update

Novel antiproliferative molecules patented at U.K. university

Belgian researchers disclose new protein kinase inhibitors

Aphios receives phase II SBIR grant to develop Alzheimer's disease therapy

Russian trial begins for Medistem's stem cell product for heart failure

Enlivex Therapeutics reports promising preliminary results in GVHD

Longitudinal data show applicability of florbetaben (18F) as a PET imaging agent in AD

NovaBay prepares to start phase IIb NVC-422 trial

Boehringer Ingelheim and Priaxon extend collaboration

Depomed starts new study of DM-1992

Almirall and BioFocus enter respiratory disease research alliance

Critical Outcome Technologies advances AML program

Johnson & Johnson highlights activities of fourth quarter 2011

Extended indication for Rebif approved in E.U.

Roche makes acquisition offer

NICE issues final guidance on Eliquis for VTE prevention in hip and knee surgery

Phase I/IIa trial launched of herbal product for Alzheimer's disease

Marina Biotech's START-FAP study advances to next stage

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...